Skip to content

A randomized controlled trial of clotrimazole combined with lotus lotion in the treatment of vulvovaginal candidiasis

A randomized controlled trial of clotrimazole combined with lotus lotion in the treatment of vulvovaginal candidiasis

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200055131
Enrollment
Unknown
Registered
2022-01-01
Start date
2021-11-01
Completion date
Unknown
Last updated
2023-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vulvovaginal candidiasis

Interventions

experimental group:Clotrimazole suppository combined with lotus external lotion
control group:Clotrimazole

Sponsors

Guangdong Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Age: 18-50; Married or with a sexual history. 2. The informed consent is signed. 3. Meet the diagnostic criteria: traditional Chinese medicine disease diagnosis and syndrome diagnosis, vulvovaginal candida disease western diagnostic criteria.

Exclusion criteria

Exclusion criteria: 1. Patients who have received systematic antifungal drugs or local antifungal drugs in the last 3 months or 2 weeks; 2. Long-term treatment with corticosteroids and immunosuppressants. 3. Pregnant women; 4. Can not accept and complete the investigation as required. 5. Allergic to treatment drugs; 6. There are significant abnormalities in blood, liver, kidney, heart and other systems; Patients with serious primary diseases such as cardiovascular, liver, kidney, brain and hematopoietic system; Suffering from mental diseases, malignant tumors and autoimmune diseases; 7. According to the 2012 Chinese VVC diagnosis and treatment standard scoring standard, the score was >=7. 8. Vaginal infection with other pathogens.

Design outcomes

Primary

MeasureTime frame
Symptom and sign score;

Countries

China

Contacts

Public Contactxuefangliang
liangxuefang2006@126.com+86 20 81887233

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026